APA

Rhee E. J., Lee W. Y., Yoon K. H., Yoo S. J., Lee I. K., Baik S. H., Kim Y. K., Lee M. K., Park K. S., Park J. Y., Cha B. S., Lee H. W., Min K. W., Bae H. Y., Kim M. J., Kim J. A., Kim D. K. & Kim S. W. (20110603). A multicenter, randomized, placebo-controlled, double-blind phase II trial evaluating the optimal dose, efficacy and safety of LC 15-0444 in patients with type 2 diabetes. : Diabetes, obesity & metabolism.

Chicago

Rhee E J, Lee W Y, Yoon K H, Yoo S J, Lee I K, Baik S H, Kim Y K, Lee M K, Park K S, Park J Y, Cha B S, Lee H W, Min K W, Bae H Y, Kim M J, Kim J A, Kim D K and Kim S W. 20110603. A multicenter, randomized, placebo-controlled, double-blind phase II trial evaluating the optimal dose, efficacy and safety of LC 15-0444 in patients with type 2 diabetes. : Diabetes, obesity & metabolism.

Harvard

Rhee E. J., Lee W. Y., Yoon K. H., Yoo S. J., Lee I. K., Baik S. H., Kim Y. K., Lee M. K., Park K. S., Park J. Y., Cha B. S., Lee H. W., Min K. W., Bae H. Y., Kim M. J., Kim J. A., Kim D. K. and Kim S. W. (20110603). A multicenter, randomized, placebo-controlled, double-blind phase II trial evaluating the optimal dose, efficacy and safety of LC 15-0444 in patients with type 2 diabetes. : Diabetes, obesity & metabolism.

MLA

Rhee E J, Lee W Y, Yoon K H, Yoo S J, Lee I K, Baik S H, Kim Y K, Lee M K, Park K S, Park J Y, Cha B S, Lee H W, Min K W, Bae H Y, Kim M J, Kim J A, Kim D K and Kim S W. A multicenter, randomized, placebo-controlled, double-blind phase II trial evaluating the optimal dose, efficacy and safety of LC 15-0444 in patients with type 2 diabetes. : Diabetes, obesity & metabolism. 20110603.